Highlights
ASX: OSL       ONCOSIL MEDICAL LTD
Last Price Today's Change   Day's Range   Trading Volume
0.059   -0.002 (3.28%)  0.059 - 0.061  450,242

Overview

 
Avg Volume (4 weeks):1,084,043
4 Weeks Range:0.058 - 0.065
4 Weeks Price Volatility (%):
14.29%
52 Weeks Range:0.033 - 0.081
52 Weeks Price Volatility (%):
54.17%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

OncoSil Medical Limited is a late-stage medical device company, which is focused on localized treatments for patients with pancreatic and liver cancer. The Company is engaged in the development of its lead product candidate, the OncoSil localized radiation therapy, for the treatment of pancreatic cancer. The Company's lead product, OncoSil, is a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous tumor. OncoSil is a silicon and phosphorus (p32) beta emitter, able to be implanted intra-tumorally via endoscopic ultrasonography in localized solid tumors of patients with pancreatic cancer. The Company focuses on an application for Conformite Europeene (CE) Mark to enable commercial sales of OncoSil in the European Union and an application for an Investigational Device Exemption (IDE) from the United States Food and Drug Administration (FDA) to enable commencement of the United States pivotal clinical study, known as OncoPac-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

628  852  648  1494 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 88E 0.01-0.001 
 1MC 0.025-0.003 
 MNS 0.46+0.095 
 ROG 0.005-0.001 
 SYA 0.275-0.01 
 PCL 0.005+0.001 
 LKE 1.38-0.215 
 DRE 0.093+0.01 
 XTC 0.01-0.001 
 TLS 4.00+0.04